Estimation of specific activity of 177Lu by `saturation assay` principle using DOTA as ligand

E-ISSN： 1874-4729|8|2|123-128

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.8, Iss.2, 2015-08, pp. : 123-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alternative method to determine Specific Activity of ¹⁷⁷Lu by HPLC

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 119-122

Bentham Science Publishers

Access to resources Recommend Favorite

Overview of Development and Formulation of ¹⁷⁷Lu-DOTA-TATE for PRRT

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 8-18

Bentham Science Publishers

Access to resources Recommend Favorite

Octreotate-Lu-177-DOTA-Tyr-3: First report of hormonal crises: 6 case reports

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Octreotate-Lu-177-DOTA-Tyr-3/yttrium-90-DOTATOC: Acute myeloid leukaemia: case report

Reactions Weekly, Vol. 1, Iss. 1401, 2012-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

[177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma

Current Radiopharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite